Legal & General Group’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-7,579
| Closed | -$47K | – | 3629 |
|
|
2022
Q1 | $47K | Buy |
7,579
+100
| +1% | +$620 | ﹤0.01% | 3015 |
|
|
2021
Q4 | $95K | Buy |
7,479
+230
| +3% | +$2.92K | ﹤0.01% | 2921 |
|
|
2021
Q3 | $665K | Buy |
7,249
+4,291
| +145% | +$394K | ﹤0.01% | 2340 |
|
|
2021
Q2 | $157K | Buy |
2,958
+588
| +25% | +$31.2K | ﹤0.01% | 2599 |
|
|
2021
Q1 | $86K | Sell |
2,370
-84
| -3% | -$3.05K | ﹤0.01% | 2660 |
|
|
2020
Q4 | $68K | Sell |
2,454
-37
| -1% | -$1.03K | ﹤0.01% | 2709 |
|
|
2020
Q3 | $124K | Sell |
2,491
-693
| -22% | -$34.5K | ﹤0.01% | 2435 |
|
|
2020
Q2 | $147K | Buy |
3,184
+1,375
| +76% | +$63.5K | ﹤0.01% | 2431 |
|
|
2020
Q1 | $84K | Sell |
1,809
-517
| -22% | -$24K | ﹤0.01% | 2462 |
|
|
2019
Q4 | $131K | Buy |
2,326
+1,846
| +385% | +$104K | ﹤0.01% | 2512 |
|
|
2019
Q3 | $12K | Hold |
480
| – | – | ﹤0.01% | 3241 |
|
|
2019
Q2 | $20K | Buy |
+480
| New | +$20K | ﹤0.01% | 3196 |
|